- May 2, 2025
The award is the highest achievement attainable for university faculty, representing outstanding contributions to research and scholarship in their field.
- April 11, 2025
After nearly three years of backorders and pharmacy scrambles, the high-demand weight-loss drugs Ozempic, Wegovy, and Mounjaro are finally back in full supply. The FDA recently declared an end to the nationwide shortage of their active ingredients, semaglutide and tirzepatide. Martin Binks, chair of the Department of Nutrition and Food Studies at George Mason University and a researcher and clinician with expertise in obesity, explains what this moment means for patients, providers, and public health.
- January 14, 2025
Yes, college students gain holiday weight too—but in the form of muscle, not fat.
- January 14, 2025
A new study from obesity researcher Martin Binks reveals that college students and older adults gain holiday weight just in different ways.
- September 6, 2024
Semaglutide May Raise Libido, Patients Say
- August 9, 2024
Beyond The Headlines: Balchem bolsters prenatal research, Ingredion reports strong Q2 results.
- August 9, 2024
Social and Structural Factors Fuel Obesity Gaps
- August 6, 2024
Interventions that focus on “modifiable” factors such as access to healthy food, health insurance, and spaces for physical activity are shown to reduce disparities, according to new interprofessional research.
- March 7, 2024
The Washington Report: Che Axum & Dr. Allison Miner
- April 18, 2023
These 7 hormones influence how much—or little—you eat. Can we influence them?